MESA BIOTECH
Mesa Biotech simplifies DNA testing. The Mesa Biotech team has achieved a dramatic simplification in the complexity of DNA and RNA molecular testing. Mesa Biotech is based in sunny San Diego, California with a satellite testing laboratory in Santa Fe, New Mexico.
MESA BIOTECH
Industry:
Biotechnology Hospital Medical Device
Founded:
2009-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.mesabiotech.com
Total Employee:
251+
Status:
Closed
Contact:
(858)800-4929
Total Funding:
39.4 M USD
Technology used in webpage:
SPF Nginx Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS Cloudflare DNS Ruby On Rails Token Google AdWords Conversion Microsoft
Similar Organizations
Carestream
CareStream provides imaging and IT systems for sectors ranging from medical and life sciences research to advanced materials production.
Cytek Biosciences
Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.
FlowMetric
FlowMetric is a provider of flow cytometry and cell sorting services.
Jefferson Health System
Jefferson Health System is a health care company that offers an extended care community for personal health.
Current Employees Featured
R. Bruce Cary Co-Founder & Vice President @ Mesa Biotech
Co-Founder & Vice President
2009-01-01
Ingo Chakravarty President and CEO @ Mesa Biotech
President and CEO
2020-04-01
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Mesa Biotech
Yonjin Venture
Yonjin Venture investment in Series B - Mesa Biotech
Key Employee Changes
| Date | New article |
|---|---|
| 2020-04-15 | Mesa Biotech Announces Ingo Chakravarty as President and CEO |
More informations about "Mesa Biotech"
Thermo Fisher Scientific Completes Acquisition of Mesa Biotech
WALTHAM, Mass., Feb. 26, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has completed its previously …See details»
Thermo Fisher Scientific Completes Acquisition of Mesa Biotech
Feb 26, 2021 · Mesa Biotech has developed the Accula System, an affordable, easy-to-use, point-of-care PCR-based testing platform for infectious disease diagnosis. The platform enables …See details»
Thermo Fisher Scientific Inc. - Thermo Fisher Scientific to Acquire ...
Jan 19, 2021 · Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a …See details»
Mesa Biotech - Crunchbase Company Profile & Funding
Mesa Biotech offers DNA and RNA molecular testing services. View contacts for Mesa Biotech to access new leads and connect with decision-makers. Mesa Biotech simplifies DNA testing. …See details»
Mesa Biotech, Inc. | LinkedIn
Mesa Biotech is a healthcare test and data company that provides actionable information through trusted, PCR-based infectious disease testing—anytime, anywhere.* Our patented Accula™ …See details»
Thermo Fisher Buys Mesa Biotech for a Total Deal of $550 Million
Jan 19, 2021 · Thermo Fisher Scientific, based in Waltham, Massachusetts, is acquiring Mesa Biotech for about $450 million in cash. There is also an additional $100 million in cash after …See details»
Thermo Fisher Scientific Completes Acquisition of Mesa Biotech
Feb 26, 2021 · Mesa Biotech has developed the Accula System, an affordable, easy-to-use, point-of-care PCR-based testing platform for infectious disease diagnosis. The platform enables …See details»
Mesa Biotech Company Profile 2024: Valuation, Investors
Developer of a molecular diagnostic test designed to treat infectious diseases.See details»
Thermo Fisher buys Mesa Biotech for $450M to bolster rapid point …
Jan 19, 2021 · Thermo Fisher Scientific on Tuesday announced it will acquire privately-held molecular diagnostic maker Mesa Biotech for $450 million in cash, with the potential for an …See details»
Thermo Fisher Inks $450M Deal to Acquire Mesa Biotech
Jan 27, 2021 · Thermo Fisher Scientific recently announced that it entered into a $450 million definitive agreement to acquire San Diego-based Mesa Biotech, Inc. and boost the availability …See details»
Thermo Fisher Scientific to Acquire Mesa Biotech
Jan 20, 2021 · Thermo Fisher Scientific, Waltham, Mass, has entered into a definitive agreement to acquire Mesa Biotech, a privately held San Diego-based molecular diagnostic company, for …See details»
Thermo Fisher Scientific Completes Acquisition of Mesa Biotech
Feb 26, 2021 · Mesa Biotech has developed the Accula System, an affordable, easy-to-use, point-of-care PCR-based testing platform for infectious disease diagnosis. The platform enables …See details»
Thermo Fisher Scientific to Acquire Point-of-Care Molecular …
Jan 19, 2021 · Mesa Biotech has developed and commercialized a PCR-based rapid point-of-care testing platform available for detecting infectious diseases including SARS-CoV-2, Influenza A …See details»
Thermo Fisher to Acquire Mesa Biotech for $450 Million
Jan 20, 2021 · Through the acquisition, Thermo Fisher will have access to Mesa’s PCR-based rapid point-of-care testing platform for detecting infectious diseases. Thermo Fisher Scientific …See details»
Thermo Fisher Scientific to Acquire Point-of-Care Molecular …
Jan 19, 2021 · Mesa Biotech has developed and commercialized a PCR-based rapid point-of-care testing platform available for detecting infectious diseases including SARS-CoV-2, Influenza A …See details»
Thermo Fisher acquires Mesa Biotech in $450M tuck-in deal
Jan 19, 2021 · Thermo Fisher Scientific Inc. has inked a definitive agreement to acquire Mesa Biotech Inc., a privately held molecular diagnostics company with a point-of-care (POC) …See details»
Thermo Fisher To Buy Covid-19 Test Maker Mesa Biotech For $450 …
Jan 19, 2021 · Thermo Fisher Scientific will pay $450 million in cash for Mesa Biotech, which launched one of the first rapid Covid-19 tests in the early days of the pandemic.See details»
Designing for simplicity: Lessons from Mesa Biotech for …
Apr 4, 2022 · Mesa Biotech (San Diego, CA) originally developed the Accula platform for the diagnosis of influenza A and B and then extended the platform to SARS-CoV-2. Mesa Biotech …See details»
Mesa Biotech to Receive Additional $13 Million from US Health …
Nov 6, 2020 · Mesa Biotech designs, develops, manufactures and commercializes next generation Rapid PCR tests, bringing the superior diagnostic performance of nucleic acid PCR …See details»
Mesa Biotech Developing Molecular Point-of-Care (PCR) …
Mar 4, 2020 · Mesa Biotech designs, develops, manufactures and commercializes next generation molecular diagnostic tests, bringing the superior diagnostic performance of nucleic …See details»